Anterogen.Co.Ltd (065660) — Cash Flow-to-Debt Ratio
Anterogen.Co.Ltd (065660) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of ₩281.98 Million could theoretically repay 0% of its total liabilities (₩1.40 Billion) in one year. See Anterogen.Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anterogen.Co.Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Anterogen.Co.Ltd across 11 annual periods. Also explore 065660 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Anterogen.Co.Ltd (2014–2024)
Year-by-year debt coverage analysis for Anterogen.Co.Ltd. For market capitalisation and broader financial context, see how much is Anterogen.Co.Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.15x | ₩-860.38 Million | ₩5.87 Billion | ▼ -47.4% |
| 2023 | -0.10x | ₩-1.99 Billion | ₩19.99 Billion | ▲ +12.7% |
| 2022 | -0.11x | ₩-1.98 Billion | ₩17.34 Billion | ▲ +25.8% |
| 2021 | -0.15x | ₩-3.05 Billion | ₩19.83 Billion | ▲ +54.3% |
| 2020 | -0.34x | ₩-4.41 Billion | ₩13.14 Billion | ▼ -230.2% |
| 2019 | -0.10x | ₩-1.65 Billion | ₩16.20 Billion | ▼ -206.9% |
| 2018 | -0.03x | ₩-1.50 Billion | ₩45.37 Billion | ▼ -200.8% |
| 2017 | 0.03x | ₩379.21 Million | ₩11.53 Billion | ▲ +135.3% |
| 2016 | -0.09x | ₩-130.65 Million | ₩1.40 Billion | ▼ -120.4% |
| 2015 | 0.46x | ₩844.49 Million | ₩1.85 Billion | ▲ +168.1% |
| 2014 | -0.67x | ₩-1.01 Billion | ₩1.51 Billion | — |